BioSyent Inc. (TSXV:RX)
Canada · Delayed Price · Currency is CAD 17.70
+0.36 (2.08%)
Nov 6, 2026, 4:00 PM EST
BioSyent Ratios and Metrics
Market cap in millions CAD. Fiscal year is January - December.
Millions CAD. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 6, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 200 | 143 | 128 | 108 | 85 | 104 | |
Market Cap Growth | 64.58% | 12.28% | 17.76% | 28.05% | -18.50% | 2.59% |
Enterprise Value | 194 | 121 | 112 | 80 | 58 | 78 |
Last Close Price | 17.70 | 12.59 | 10.70 | 8.80 | 6.55 | 7.68 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 6, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 20.72 | 15.91 | 17.56 | 16.79 | 15.52 | 16.54 |
Forward PE | 17.10 | 14.98 | 14.52 | 17.23 | 13.86 | 18.77 |
PS Ratio | 3.60 | 3.33 | 3.65 | 3.43 | 3.03 | 3.63 |
PB Ratio | 4.37 | 3.46 | 3.65 | 3.12 | 2.54 | 3.29 |
P/TBV Ratio | 10.29 | 3.89 | 4.24 | 3.21 | 2.62 | 3.38 |
P/FCF Ratio | 17.47 | 15.98 | 14.80 | 21.71 | 17.28 | 22.64 |
P/OCF Ratio | 17.40 | 15.91 | 14.74 | 21.45 | 17.11 | 22.23 |
PEG Ratio | - | 1.49 | 1.49 | 1.49 | 1.49 | 9.13 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 6, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 3.49 | 2.81 | 3.19 | 2.55 | 2.09 | 2.74 |
EV/EBITDA Ratio | 12.88 | 10.16 | 11.64 | 10.54 | 8.03 | 9.26 |
EV/EBIT Ratio | 14.70 | 10.80 | 12.17 | 10.76 | 8.36 | 9.58 |
EV/FCF Ratio | 16.96 | 13.48 | 12.94 | 16.10 | 11.90 | 17.08 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 6, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.07 | 0.02 | 0.03 | 0.04 | 0.04 | 0.05 |
Debt / EBITDA Ratio | 0.21 | 0.07 | 0.11 | 0.16 | 0.19 | 0.18 |
Debt / FCF Ratio | 0.27 | 0.09 | 0.12 | 0.24 | 0.28 | 0.34 |
Net Debt / Equity Ratio | -0.13 | -0.67 | -0.43 | -0.72 | -0.82 | -0.84 |
Net Debt / EBITDA Ratio | -0.39 | -2.34 | -1.55 | -3.27 | -3.76 | -3.15 |
Net Debt / FCF Ratio | -0.51 | -3.10 | -1.73 | -5.00 | -5.57 | -5.81 |
Asset Turnover | 1.07 | 0.95 | 0.85 | 0.77 | 0.72 | 0.81 |
Inventory Turnover | 1.90 | 1.72 | 1.28 | 1.15 | 1.50 | 2.80 |
Quick Ratio | 1.13 | 4.59 | 3.49 | 5.36 | 5.63 | 7.49 |
Current Ratio | 2.07 | 5.52 | 4.53 | 6.48 | 6.49 | 8.24 |
Return on Equity (ROE) | 23.65% | 23.57% | 20.84% | 18.97% | 16.82% | 21.53% |
Return on Assets (ROA) | 15.90% | 15.41% | 13.85% | 11.39% | 11.24% | 14.46% |
Return on Invested Capital (ROIC) | 24.56% | 49.68% | 45.66% | 71.34% | 93.57% | 156.76% |
Return on Capital Employed (ROCE) | 28.30% | 26.50% | 25.50% | 20.80% | 20.10% | 24.80% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 6, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 4.83% | 6.29% | 5.69% | 5.96% | 6.44% | 6.04% |
FCF Yield | 5.72% | 6.26% | 6.76% | 4.61% | 5.79% | 4.42% |
Dividend Yield | 1.24% | 1.57% | 1.59% | 1.73% | 0.57% | - |
Payout Ratio | 24.01% | 24.99% | 28.61% | 29.61% | 8.87% | - |
Buyback Yield / Dilution | 0.72% | 2.55% | 2.98% | 2.95% | 2.57% | 1.70% |
Total Shareholder Return | 1.97% | 4.12% | 4.57% | 4.68% | 3.14% | 1.70% |